✦ LIBER ✦

Mo1215 Serum Golimumab Exposure and the Incidence of Selected Safety Events in Patients With Ulcerative Colitis Following Treatment With Golimumab: An Exploratory Analysis of the PURSUIT Study Data

✍ Scribed by Adedokun, Omoniyi J.; Xu, Zhenhua; Marano, Colleen W.; Strauss, Richard; Zhang, Hongyan; Johanns, Jewel; Zhou, Honghui; Davis, Hugh M.; Liao, Sam; Colombel, Jean-Frederic; Reinisch, Walter; Feagan, Brian G.; Rutgeerts, Paul J.; Gibson, Peter R.; Sandborn, William

Book ID: 122300345
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 219 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(14)62130-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1214 Long-Term Safety and Efficacy of

Mo1214 Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the PURSUIT-SC Maintenance Study Extension

✍ Gibson, Peter R.; Reinisch, Walter; Sandborn, William; Feagan, Brian G.; Marano, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 190 KB

OP009 Long-term safety and efficacy of g

OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension

✍ Reinisch, W.; Gibson, P.; Sandborn, W.J.; Feagan, B.G.; Marano, C.; Strauss, R.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 65 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB